BIBRINA Trademark

Trademark Overview

On Monday, January 9, 2023, a trademark application was filed for BIBRINA with the United States Patent and Trademark Office. The USPTO has given the BIBRINA trademark a serial number of 97747050. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, March 17, 2025. This trademark is owned by Bayer Aktiengesellschaft. The BIBRINA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for humans for treatment of gynecological related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of hormone related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of cardiological related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of oncological related diseases, disorders and deficiencies
bibrina

General Information

Serial Number97747050
Word MarkBIBRINA
Filing DateMonday, January 9, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, March 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for humans for treatment of gynecological related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of hormone related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of cardiological related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of oncological related diseases, disorders and deficiencies
Translation of Words in MarkThe word "BIBRINA" has no meaning in a foreign language

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Thursday, January 12, 2023NEW APPLICATION ENTERED
Friday, January 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 30, 2023ASSIGNED TO EXAMINER
Saturday, November 4, 2023NON-FINAL ACTION WRITTEN
Saturday, November 4, 2023NON-FINAL ACTION E-MAILED
Saturday, November 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 24, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2024SOU EXTENSION 1 GRANTED
Tuesday, September 24, 2024SOU EXTENSION 1 FILED
Monday, December 2, 2024REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, December 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 17, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 17, 2025SOU EXTENSION 2 FILED
Monday, March 17, 2025SOU EXTENSION 2 GRANTED
Tuesday, March 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

bibrina diseases disorders deficiencies pharmaceutical related humans preparations treatment oncological cardiological